INTERFEROME v2.0: An updated database of annotated interferon-regulated genes

Nucleic Acids Research

Volumn 41, Issue D1, 2013, Pages

  Rusinova, Irina ^a   Forster, Sam ^a   Yu, Simon ^a   Kannan, Anitha ^a   Masse, Marion ^a,b   Cumming, Helen ^a   Chapman, Ross ^a   Hertzog, Paul J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CELL TYPE; CHROMOSOMAL LOCALIZATION; COMPUTER PROGRAM; CONCENTRATION RESPONSE; FACTUAL DATABASE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; INFORMATION PROCESSING; INNATE IMMUNITY; INTERFEROME V2.0 DATABASE; INTERFERON REGULATED GENE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATOR GENE; SECONDARY ANALYSIS; STANDARDIZATION; STATISTICAL ANALYSIS; TISSUE SPECIFICITY;

ANIMALS; DATABASES, GENETIC; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; INTERNET; MICE; MOLECULAR SEQUENCE ANNOTATION; TRANSCRIPTOME;

MUS;

EID: 84876575052     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks1215     Document Type: Article

References (37)

1. Isaacs, A. and Lindenmann, J. (1957) Virus interference: part I. The interferon. Proc. R. Soc. Lond. B Biol. Sci., 147, 258-267.
2. Nagano, Y. and Kojima, Y. (1954) Pouvoir immunisant du virus vaccinal inactive par des rayons ultraviolets. C. R. Séances Soc. Biol. fil., 148, 1700-1702.
3. Pestka, S., Krause, C.D. and Walter, M.R. (2004) Interferons, interferon-like cytokines, and their receptors. Immunol. Rev., 202, 8-32.
4. Hertzog, P.J. (2012) Overview. Type I interferons as primers, activators and inhibitors of innate and adaptive immune responses. Immunol. Cell Biol., 90, 471-473.
5. Hervas-Stubbs, S., Perez-Gracia, J.L., Rouzaut, A., Sanmamed, M.F., Le Bon, A. and Melero, I. (2011) Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res., 17, 2619-2627.
6. Lamers, M.H., Kirgiz, O.O., Heidrich, B., Wedemeyer, H. and Drenth, J.P. (2012) Interferon-alpha for patients with chronic hepatitis delta: a systematic review of randomized clinical trials. Antivir. Ther., 17, 1029-1037.
7. Croze, E., Yamaguchi, K.D., Knappertz, V., Reder, A.T. and Salamon, H. (2012) Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. Pharmacogenomics J. June 19 (doi:10.1038/tpj. 2012.27; epub ahead of print).
8. Kirkwood, J. (2002) Cancer immunotherapy: the interferon-alpha experience. Semin. Oncol., 29(3 Suppl 7), 18-26.
9. Lichtman, E.I., Helfgott, S.M. and Kriegel, M.A. (2012) Emerging therapies for systemic lupus erythematosus-focus on targeting interferon-alpha. Clin. Immunol., 143, 210-221.
10. Trinchieri, G. (2010) Type I interferon: friend or foe? J. Exp. Med., 207, 2053-2063.
11. de Weerd, N.A., Samarajiwa, S.A. and Hertzog, P.J. (2007) Type I interferon receptors: biochemistry and biological functions. J. Biol. Chem., 282, 20053-20057.
12. Stark, G.R. and Darnell, J.E. Jr (2012) The JAK-STAT pathway at twenty. Immunity, 36, 503-514.
13. Platanias, L.C. (2005) Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol., 5, 375-386.
14. Der, S.D., Zhou, A., Williams, B.R. and Silverman, R.H. (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA, 95, 15623-15628.
15. Noppert, S.J., Fitzgerald, K.A. and Hertzog, P.J. (2007) The role of type I interferons in TLR responses. Immunol. Cell Biol., 85, 446-457.
16. Hwang, S.Y., Hertzog, P.J., Holland, K.A., Sumarsono, S.H., Tymms, M.J., Hamilton, J.A., Whitty, G., Bertoncello, I. and Kola, I. (1995) A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl Acad. Sci. USA, 92, 11284-11288.
17. Muller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R.M. and Aguet, M. (1994) Functional role of type I and type II interferons in antiviral defense. Science, 264, 1918-1921.
18. Vance, R.E., Isberg, R.R. and Portnoy, D.A. (2009) Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe, 6, 10-21.
19. Takeuchi, O. and Akira, S. (2010) Pattern recognition receptors and inflammation. Cell, 140, 805-820.
20. Samarajiwa, S.A., Forster, S., Auchettl, K. and Hertzog, P.J. (2009) INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res., 37, D852-D857.
21. Hertzog, P., Forster, S. and Samarajiwa, S. (2011) Systems biology of interferon responses. J. Interferon Cytokine Res., 31, 5-11.
22. Vallon-Christersson, J., Nordborg, N., Svensson, M. and Hakkinen, J. (2009) BASE-2nd generation software for microarray data management and analysis. BMC Bioinformatics, 10, 330.
23. Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U. and Speed, T.P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
24. Bolstad, B.M., Irizarry, R.A., Astrand, M. and Speed, T.P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 19, 185-193.
25. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B. and Speed, T.P. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res., 31, e15.
26. Smyth, G.K., Michaud, J. and Scott, H.S. (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics, 21, 2067-2075.
27. Smyth, G.K. and Speed, T. (2003) Normalization of cDNA microarray data. Methods, 31, 265-273.
28. Pan, W. (2002) A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics, 18, 546-554.
29. Dudoit, S., Yang, Y.H., Callow, M.J. and Speed, T.P. (2002) Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Stat Sin, 12, 111-139.
30. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
31. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C.L., Haase, J., Janes, J., Huss, J.W. III et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol., 10, R130.
32. Forbes, R.L., Wark, P.A.B., Murphy, V.E. and Gibson, P.G. (2012) Pregnant women have attenuated innate interferon responses to 2009 pandemic influenza A virus subtype H1N1. J. Infect. Dis., 206, 646-653.
33. Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M.L., Bassendine, M., Spengler, U., Dore, G.J., Powell, E. et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat. Genet., 41, U1100-U1174.
34. Harman, A.N., Lai, J., Turville, S., Samarajiwa, S., Gray, L., Marsden, V., Mercier, S.K., Jones, K., Nasr, N., Rustagi, A. et al. (2011) HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood, 118, 298-308.
35. Berry, M.P., Graham, C.M., McNab, F.W., Xu, Z., Bloch, S.A., Oni, T., Wilkinson, K.A., Banchereau, R., Skinner, J., Wilkinson, R.J. et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 466, 973-977.
36. Bidwell, B.N., Slaney, C.Y., Withana, N.P., Forster, S., Cao, Y., Loi, S., Andrews, D., Mikeska, T., Mangan, N.E., Samarajiwa, S.A. et al. (2012) Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med.
37. Ruiz-Riol, M., Barnils Mdel, P., Colobran Oriol, R., Pla, A.S., Borras Serres, F.E., Lucas-Martin, A., Martinez Caceres, E.M. and Pujol-Borrell, R. (2011) Analysis of the cumulative changes in Graves' disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors. J. Autoimmun., 36, 189-200.